Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
47
UTI Quote, Financials, Valuation and Earnings
Last price:
$27.18
Seasonality move
:
3.11%
Day range:
$26.80 - $27.17
52-week range:
$21.29 - $36.32
Dividend yield:
0%
P/E ratio:
23.89x
P/S ratio:
1.80x
P/B ratio:
4.50x
Volume:
548.6K
Avg. volume:
908.8K
1-year change:
6.53%
Market cap:
$1.5B
Revenue:
$835.6M
EPS (TTM):
$1.13
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $335.1M | $418.8M | $607.4M | $732.7M | $835.6M | |
| Revenue Growth (YoY) | 11.41% | 24.97% | 45.05% | 20.63% | 14.05% | |
| Cost of Revenues | $167.9M | $208.4M | $331.7M | $387.1M | $422.9M | |
| Gross Profit | $167.2M | $210.4M | $275.7M | $345.6M | $412.7M | |
| Gross Profit Margin | 49.89% | 50.23% | 45.39% | 47.17% | 49.39% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $153.3M | $189.2M | $256.1M | $289.3M | $331.7M | |
| Other Inc / (Exp) | $518K | -$438K | $483K | $496K | -- | |
| Operating Expenses | $152.3M | $182.1M | $252M | $286.7M | $329.2M | |
| Operating Income | $14.8M | $28.3M | $23.7M | $58.9M | $83.5M | |
| Net Interest Expenses | $279K | $1.8M | $8.8M | $10.5M | $6.4M | |
| EBT. Incl. Unusual Items | $15.2M | $20.4M | $18.1M | $56.2M | $84.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $602K | -$5.4M | $5.8M | $14.2M | $21.3M | |
| Net Income to Company | $14.6M | $25.8M | $12.3M | $42M | $63M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $10.9M | $18M | $9.6M | $39.1M | $63M | |
| Basic EPS (Cont. Ops) | $0.17 | $0.39 | $0.13 | $0.77 | $1.16 | |
| Diluted EPS (Cont. Ops) | $0.17 | $0.38 | $0.13 | $0.75 | $1.13 | |
| Weighted Average Basic Share | $32.8M | $33.2M | $34M | $49.4M | $54.3M | |
| Weighted Average Diluted Share | $33.1M | $33.7M | $34.5M | $50.9M | $55.6M | |
| EBITDA | $44.5M | $61.1M | $69.5M | $110.1M | $140.3M | |
| EBIT | $14.8M | $28.3M | $23.7M | $58.9M | $83.5M | |
| Revenue (Reported) | $335.1M | $418.8M | $607.4M | $732.7M | $835.6M | |
| Operating Income (Reported) | $14.8M | $28.3M | $23.7M | $58.9M | $83.5M | |
| Operating Income (Adjusted) | $14.8M | $28.3M | $23.7M | $58.9M | $83.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $97.5M | $110.6M | $170.3M | $196.4M | $222.4M | |
| Revenue Growth (YoY) | 27.72% | 13.5% | 53.92% | 15.3% | 13.28% | |
| Cost of Revenues | $45M | $57.2M | $93.2M | $99.4M | $112.8M | |
| Gross Profit | $52.5M | $53.4M | $77.1M | $97M | $109.6M | |
| Gross Profit Margin | 53.84% | 48.28% | 45.3% | 49.4% | 49.27% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $39.9M | $50.3M | $66.8M | $71M | $85.2M | |
| Other Inc / (Exp) | $10K | -$102K | -$57K | $143K | -- | |
| Operating Expenses | $38.9M | $45M | $66.8M | $71M | $84.6M | |
| Operating Income | $13.6M | $8.5M | $10.3M | $26M | $25M | |
| Net Interest Expenses | $176K | $752K | $2.4M | $2.5M | $1.1M | |
| EBT. Incl. Unusual Items | $12.6M | $3M | $9.2M | $25.4M | $25.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $524K | $202K | $2.5M | $6.5M | $6.8M | |
| Net Income to Company | $12M | $2.8M | $6.7M | -$369K | -$25.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $8.4M | $2.2M | $4.7M | $18.8M | $18.8M | |
| Basic EPS (Cont. Ops) | $0.22 | $0.03 | $0.10 | $0.35 | $0.34 | |
| Diluted EPS (Cont. Ops) | $0.21 | $0.03 | $0.10 | $0.34 | $0.34 | |
| Weighted Average Basic Share | $32.8M | $33.8M | $34.1M | $53.8M | $54.4M | |
| Weighted Average Diluted Share | $33.4M | $34.3M | $34.8M | $55.4M | $55.7M | |
| EBITDA | $20.9M | $16.5M | $22.1M | $39.2M | $39.8M | |
| EBIT | $13.6M | $8.5M | $10.3M | $26M | $25M | |
| Revenue (Reported) | $97.5M | $110.6M | $170.3M | $196.4M | $222.4M | |
| Operating Income (Reported) | $13.6M | $8.5M | $10.3M | $26M | $25M | |
| Operating Income (Adjusted) | $13.6M | $8.5M | $10.3M | $26M | $25M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $335.1M | $418.8M | $607.4M | $732.7M | $835.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $167.9M | $208.4M | $330.3M | $384.9M | $422.9M | |
| Gross Profit | $167.2M | $210.4M | $277.1M | $347.8M | $412.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $153.3M | $189.2M | $256.1M | $289.3M | $331.7M | |
| Other Inc / (Exp) | $518K | -$438K | $483K | $496K | -- | |
| Operating Expenses | $152.3M | $182.1M | $253.4M | $288.3M | $329.2M | |
| Operating Income | $14.8M | $28.3M | $23.7M | $59.5M | $83.5M | |
| Net Interest Expenses | $309K | $1.8M | $8.8M | $9.5M | $6.4M | |
| EBT. Incl. Unusual Items | $15.2M | $20.4M | $18.1M | $56.2M | $84.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $602K | -$5.4M | $5.8M | $14.2M | $21.3M | |
| Net Income to Company | $14.6M | $25.8M | $12.3M | $42M | $63M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $10.3M | $17.6M | $9M | $39.1M | $63M | |
| Basic EPS (Cont. Ops) | $0.15 | $0.38 | $0.11 | $0.76 | $1.16 | |
| Diluted EPS (Cont. Ops) | $0.15 | $0.37 | $0.11 | $0.74 | $1.13 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $44.5M | $61.1M | $69.5M | $110.7M | $140.3M | |
| EBIT | $14.8M | $28.3M | $23.7M | $59.5M | $83.5M | |
| Revenue (Reported) | $335.1M | $418.8M | $607.4M | $732.7M | $835.6M | |
| Operating Income (Reported) | $14.8M | $28.3M | $23.7M | $59.5M | $83.5M | |
| Operating Income (Adjusted) | $14.8M | $28.3M | $23.7M | $59.5M | $83.5M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $418.8M | $607.4M | $732.7M | $835.6M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $208.4M | $330.3M | $384.9M | $422.9M | -- | |
| Gross Profit | $210.4M | $277.1M | $347.8M | $412.7M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $189.2M | $256.1M | $289.3M | $331.7M | -- | |
| Other Inc / (Exp) | -$438K | $483K | $496K | -$26K | -- | |
| Operating Expenses | $182.1M | $253.4M | $288.3M | $329.2M | -- | |
| Operating Income | $28.3M | $23.7M | $59.5M | $83.5M | -- | |
| Net Interest Expenses | $1.8M | $8.8M | $9.5M | $6.4M | -- | |
| EBT. Incl. Unusual Items | $20.4M | $18.1M | $56.2M | $84.3M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$5.4M | $5.8M | $14.2M | $21.3M | -- | |
| Net Income to Company | $25.8M | $12.3M | $42M | $63M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $17.6M | $9M | $39.1M | $63M | -- | |
| Basic EPS (Cont. Ops) | $0.38 | $0.11 | $0.76 | $1.16 | -- | |
| Diluted EPS (Cont. Ops) | $0.37 | $0.11 | $0.74 | $1.13 | -- | |
| Weighted Average Basic Share | $132.9M | $135.9M | $197.8M | $217.2M | -- | |
| Weighted Average Diluted Share | $134.5M | $137.9M | $202.6M | $222.2M | -- | |
| EBITDA | $61.1M | $69.5M | $110.7M | $140.3M | -- | |
| EBIT | $28.3M | $23.7M | $59.5M | $83.5M | -- | |
| Revenue (Reported) | $418.8M | $607.4M | $732.7M | $835.6M | -- | |
| Operating Income (Reported) | $28.3M | $23.7M | $59.5M | $83.5M | -- | |
| Operating Income (Adjusted) | $28.3M | $23.7M | $59.5M | $83.5M | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $146M | $98.9M | $156.9M | $167.5M | $175.9M | |
| Short Term Investments | -- | $28.9M | -- | -- | -- | |
| Accounts Receivable, Net | $19M | $18.9M | $26.6M | $31.1M | $47M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $11.5M | $10.1M | $11.3M | $12.2M | $13.2M | |
| Other Current Assets | $8.1M | $8.8M | $7.5M | $5.2M | -- | |
| Total Current Assets | $183.4M | $136M | $205M | $222M | $246.6M | |
| Property Plant And Equipment | $281.1M | $346.3M | $443M | $423.6M | $464.7M | |
| Long-Term Investments | $35.2M | $32.3M | $32.7M | $43.5M | $58.1M | |
| Goodwill | $8.2M | $16.9M | $28.5M | $28.5M | -- | |
| Other Intangibles | $124K | $14.2M | $19M | $18.2M | -- | |
| Other Long-Term Assets | $9.1M | $6M | $10.8M | $12.5M | -- | |
| Total Assets | $560.7M | $604.3M | $740.7M | $744.6M | $826.1M | |
| Accounts Payable | $13.7M | $21.7M | $14.4M | $26.3M | $39.1M | |
| Accrued Expenses | $14.5M | $16.5M | $19.2M | $21.9M | -- | |
| Current Portion Of Long-Term Debt | $876K | $1.1M | $2.5M | $2.7M | -- | |
| Current Portion Of Capital Lease Obligations | $14.1M | $13M | $22.5M | $22.2M | -- | |
| Other Current Liabilities | $2.4M | $2.7M | $4M | $3.7M | -- | |
| Total Current Liabilities | $132.7M | $137.7M | $184.7M | $205M | $229.7M | |
| Long-Term Debt | $183.1M | $195.7M | $324.6M | $269.8M | $259.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $372.2M | $388.9M | $514.7M | $484.3M | $498M | |
| Common Stock | $3K | $3K | $3K | $5K | $5K | |
| Other Common Equity Adj | -$279K | $2.2M | $2.5M | $1.1M | -- | |
| Common Equity | $119.7M | $148.9M | $159.5M | $260.2M | $328.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $188.5M | $215.4M | $226M | $260.2M | $328.1M | |
| Total Liabilities and Equity | $560.7M | $604.3M | $740.7M | $744.6M | $826.1M | |
| Cash and Short Terms | $146M | $98.9M | $156.9M | $167.5M | $175.9M | |
| Total Debt | $184M | $196.8M | $327.1M | $272.5M | $261.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $146M | $98.9M | $156.9M | $167.5M | $175.9M | |
| Short Term Investments | -- | $28.9M | -- | -- | -- | |
| Accounts Receivable, Net | $19M | $18.9M | $26.6M | $31.1M | $47M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $11.5M | $10.1M | $11.3M | $12.2M | $13.2M | |
| Other Current Assets | $8.1M | $8.8M | $7.5M | $5.2M | -- | |
| Total Current Assets | $183.4M | $136M | $205M | $222M | $246.6M | |
| Property Plant And Equipment | $281.1M | $346.3M | $443M | $423.6M | $464.7M | |
| Long-Term Investments | $35.2M | $32.3M | $32.7M | $43.5M | $58.1M | |
| Goodwill | $8.2M | $16.9M | $28.5M | $28.5M | -- | |
| Other Intangibles | $124K | $14.2M | $19M | $18.2M | -- | |
| Other Long-Term Assets | $9.1M | $6M | $10.8M | $12.5M | -- | |
| Total Assets | $560.7M | $604.3M | $740.7M | $744.6M | $826.1M | |
| Accounts Payable | $13.7M | $21.7M | $14.4M | $26.3M | $39.1M | |
| Accrued Expenses | $14.5M | $16.5M | $19.2M | $21.9M | -- | |
| Current Portion Of Long-Term Debt | $876K | $1.1M | $2.5M | $2.7M | -- | |
| Current Portion Of Capital Lease Obligations | $14.1M | $13M | $22.5M | $22.2M | -- | |
| Other Current Liabilities | $2.4M | $2.7M | $4M | $3.7M | -- | |
| Total Current Liabilities | $132.7M | $137.7M | $184.7M | $205M | $229.7M | |
| Long-Term Debt | $183.1M | $195.7M | $324.6M | $269.8M | $259.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $372.2M | $388.9M | $514.7M | $484.3M | $498M | |
| Common Stock | $3K | $3K | $3K | $5K | $5K | |
| Other Common Equity Adj | -$279K | $2.2M | $2.5M | $1.1M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $188.5M | $215.4M | $226M | $260.2M | $328.1M | |
| Total Liabilities and Equity | $560.7M | $604.3M | $740.7M | $744.6M | $826.1M | |
| Cash and Short Terms | $146M | $98.9M | $156.9M | $167.5M | $175.9M | |
| Total Debt | $184M | $196.8M | $327.1M | $272.5M | $261.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14.6M | $25.8M | $12.3M | $42M | $63M | |
| Depreciation & Amoritzation | $29.6M | $32.8M | $45.8M | $51.2M | $56.8M | |
| Stock-Based Compensation | $1.7M | $4.3M | $3.8M | $8.6M | $9.2M | |
| Change in Accounts Receivable | $6.8M | $816K | -$5.7M | -$17.9M | -$44M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $54.9M | $45.7M | $48.6M | $85.9M | $97.3M | |
| Capital Expenditures | $61.6M | $79.5M | $56.7M | $24.3M | $42M | |
| Cash Acquisitions | -- | $26.5M | $16.4M | -- | -- | |
| Cash From Investing | -$23M | -$134.6M | -$44.1M | -$24M | -$87.9M | |
| Dividends Paid (Ex Special Dividend) | $5.3M | $5.2M | $5.1M | $1.1M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $31.2M | $38M | $90M | $41M | -- | |
| Long-Term Debt Repaid | -$383K | -$19.2M | -$1.8M | -$77.5M | -- | |
| Repurchase of Common Stock | -- | -- | -- | $11.5M | -- | |
| Other Financing Activities | -$693K | -$1M | -$1.3M | -$2.2M | -- | |
| Cash From Financing | $25.1M | $13M | $82.4M | -$51.3M | -$42.8M | |
| Beginning Cash (CF) | $146M | $70M | $156.9M | $167.5M | $134.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $57.1M | -$76M | $86.9M | $10.5M | -$33.3M | |
| Ending Cash (CF) | $203M | -$6M | $243.9M | $178M | $100.8M | |
| Levered Free Cash Flow | -$6.7M | -$33.8M | -$8.1M | $61.6M | $55.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $12M | $2.8M | $6.7M | -$369K | -$25.5M | |
| Depreciation & Amoritzation | $7.3M | $8M | $11.7M | $13.2M | $14.8M | |
| Stock-Based Compensation | $547K | $1.1M | $33K | $2.9M | $2.7M | |
| Change in Accounts Receivable | -$863K | $8.1M | -$2.8M | -$3.5M | -$18M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $40.4M | $38.1M | $53.8M | $67.5M | $57.1M | |
| Capital Expenditures | $7.3M | $9.8M | $7.8M | $7.5M | $16.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6.3M | -$38.7M | -$7.8M | -$7.5M | -$9.6M | |
| Dividends Paid (Ex Special Dividend) | $2.6M | $2.5M | $2.5M | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $5M | -- | |
| Long-Term Debt Repaid | -$221K | -$223K | -$609K | -$16.6M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$20K | -$41K | -$52K | -$36K | -- | |
| Cash From Financing | -$2.9M | -$2.8M | -$3.2M | -$11.7M | $13.2M | |
| Beginning Cash (CF) | $146M | $70M | $156.9M | $167.5M | $134.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $31.2M | -$3.3M | $42.8M | $48.4M | $60.7M | |
| Ending Cash (CF) | $177.2M | $66.7M | $199.8M | $215.8M | $194.9M | |
| Levered Free Cash Flow | $33.1M | $28.3M | $46M | $60M | $40.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14.6M | $25.8M | $12.3M | $42M | $63M | |
| Depreciation & Amoritzation | $29.6M | $32.8M | $45.8M | $51.2M | $56.8M | |
| Stock-Based Compensation | $1.7M | $4.3M | $3.8M | $8.6M | $9.2M | |
| Change in Accounts Receivable | $6.8M | $816K | -$5.7M | -$17.9M | -$44M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $54.9M | $45.7M | $48.6M | $85.9M | $97.3M | |
| Capital Expenditures | $61.6M | $79.5M | $56.7M | $24.3M | $42M | |
| Cash Acquisitions | -- | $26.5M | $16.4M | -- | -- | |
| Cash From Investing | -$23M | -$134.6M | -$44.1M | -$24M | -$87.9M | |
| Dividends Paid (Ex Special Dividend) | $5.3M | $5.2M | $5.1M | $1.1M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $38M | $90M | $41M | -- | |
| Long-Term Debt Repaid | -$383K | -$19.2M | -$1.8M | -$77.5M | -- | |
| Repurchase of Common Stock | -- | -- | -- | $11.5M | -- | |
| Other Financing Activities | -$693K | -$1M | -$1.3M | -$2.2M | -- | |
| Cash From Financing | $25.1M | $13M | $82.4M | -$51.3M | -$42.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $57.1M | -$76M | $86.9M | $10.5M | -$33.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$6.7M | -$33.8M | -$8.1M | $61.6M | $55.4M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $25.8M | $12.3M | $42M | $63M | -- | |
| Depreciation & Amoritzation | $32.8M | $45.8M | $51.2M | $56.8M | -- | |
| Stock-Based Compensation | $4.3M | $3.8M | $8.6M | $9.2M | -- | |
| Change in Accounts Receivable | $816K | -$5.7M | -$17.9M | -$44M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $45.7M | $48.6M | $85.9M | $97.3M | -- | |
| Capital Expenditures | $79.5M | $56.7M | $24.3M | $42M | -- | |
| Cash Acquisitions | $26.5M | $16.4M | -- | -- | -- | |
| Cash From Investing | -$134.6M | -$44.1M | -$24M | -$87.9M | -- | |
| Dividends Paid (Ex Special Dividend) | $5.2M | $5.1M | $1.1M | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $38M | $90M | $41M | -- | -- | |
| Long-Term Debt Repaid | -$19.2M | -$1.8M | -$77.5M | -$31.3M | -- | |
| Repurchase of Common Stock | -- | -- | $11.5M | -- | -- | |
| Other Financing Activities | -$1M | -$1.3M | -$2.2M | -$4.5M | -- | |
| Cash From Financing | $13M | $82.4M | -$51.3M | -$42.8M | -- | |
| Beginning Cash (CF) | $327.4M | $562.4M | $556M | $485.8M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$76M | $86.9M | $10.5M | -$33.3M | -- | |
| Ending Cash (CF) | $251.4M | $649.3M | $566.5M | $452.5M | -- | |
| Levered Free Cash Flow | -$33.8M | -$8.1M | $61.6M | $55.4M | -- | |
Get UTI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
UTI
Sector
P/E ratio
23.89x
17.37x
PEG ratio
0.46x
0.11x
P/B ratio
4.50x
1.33x
Price / LTM sales
1.80x
0.57x
Growth Metrics
UTI
Sector
Revenue growth
13.28%
3.54%
Earnings growth
-1%
--
Revenue (5-year growth)
22.68%
3.17%
Earnings forecast
$0.32
$0.25
Profitability
UTI
Sector
Profitability FY 2025
$412.7M
$298.2M
Return on invested capital
11.07%
3.4%
Return on assets
8.32%
2.25%
Return on equity
21.45%
5.88%
Earnings Date
Last Earnings Date
Nov
19
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Feb
18
Balance Sheet
UTI
Sector
Total cash
$175.9M
$130M
Short term investments
--
$41M
Total assets
$826.1M
$1.1B
Long term debt
$261.9M
$36M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
